Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Clobetasol 0.05% ointment 25% in White soft paraffin
1304000G0AACKCK
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% ointment 30% in White soft paraffin
1304000G0AACSCS
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% ointment 50% in Emulsifying ointment
1304000G0AADJDJ
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasone 0.05% cream 50% in Aqueous cream
1304000H0AACMCM
|
Clobetasone butyrate (Topical) | Clobetasone butyrate | Skin | No data available |
|
Clobetasone 0.05% cream 50% in White soft paraffin
1304000H0AACPCP
|
Clobetasone butyrate (Topical) | Clobetasone butyrate | Skin | No data available |
|
Clobetasone 0.05% ointment 50% in White soft paraffin
1304000H0AACKCK
|
Clobetasone butyrate (Topical) | Clobetasone butyrate | Skin | No data available |
|
Clotrimazole 1% powder
1310020H0AAADAD
|
Clotrimazole (Topical) | Clotrimazole | Skin | No data available |
|
Coal tar 0.5% in Yellow soft paraffin
1305020C0AAETET
|
Coal tar/tar (Topical) | Tars | Skin | No data available |
|
Coal tar 1% in Aqueous cream
1305020C0AAEZEZ
|
Coal tar/tar (Topical) | Tars | Skin | No data available |
|
Coal tar 1% in Emulsifying ointment
1305020C0AAGWGW
|
Coal tar/tar (Topical) | Tars | Skin | No data available |
|
Coal tar 1% in Yellow soft paraffin
1305020C0AAEUEU
|
Coal tar/tar (Topical) | Tars | Skin | No data available |
|
Coal tar 10% in Aqueous cream
1305020C0AAFAFA
|
Coal tar/tar (Topical) | Tars | Skin | No data available |
|
Coal tar 10% in Clobetasol 0.05% ointment
1304000G0AADNDN
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Coal tar 10% in Generic Unguentum M cream
1305020C0AAFSFS
|
Coal tar/tar (Topical) | Tars | Skin | No data available |
|
Coal tar 10% in Hydrocortisone 1% cream
1305020I0AAANAN
|
Coal tar and corticosteroids | Coal tar and corticosteroid preparations | Skin | No data available |
|
Coal tar 10%/Salicylic acid 3% in Cetomacrogol (Formula A)
1305020C0AAGQGQ
|
Coal tar/tar (Topical) | Tars | Skin | No data available |
|
Coal tar 12% / Salicylic acid 2% in Emulsifying ointment
1305020C0AAEGEG
|
Coal tar/tar (Topical) | Tars | Skin | No data available |
|
Coal tar 12% in Yellow soft paraffin
1305020C0AAGTGT
|
Coal tar/tar (Topical) | Tars | Skin | No data available |
|
Coal tar 12%/Salicylic acid 2% in Hydrocortisone 1%
1305020I0AAAKAK
|
Coal tar and corticosteroids | Coal tar and corticosteroid preparations | Skin | No data available |
|
Coal tar 15% in Betamethasone valerate 0.025% ointment
1304000F0AAEYEY
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | No data available |
|
Coal tar 2% / Salic acid 2% / Sulfur 2% in Gen Unguen M crm
1305020C0AAHBHB
|
Coal tar/tar (Topical) | Tars | Skin | No data available |
|
Coal tar 2% in Aqueous cream
1305020C0AAGXGX
|
Coal tar/tar (Topical) | Tars | Skin | No data available |
|
Coal tar 2% in Betamethasone dipropionate 0.05% ointment
1304000D0AACECE
|
Betamethasone esters | Betamethasone esters | Skin | No data available |
|
Coal tar 2% in Betamethasone valerate 0.1% cream
1304000F0AAFAFA
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | No data available |
|
Coal tar 2% in Betamethasone valerate 0.1% ointment
1304000F0AAFBFB
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.